Rockstar Breakfast

Are you looking for an opportunity to network with local senior leaders? If so, this is THE event for you. Join Meredith Fisher and Gregory Verdine for an engaging conversation. Registration is for WEST MEMBERS ONLY and will be limited to a maximum of 25 participants to ensure an intimate experience. 

Meredith Fisher is a Partner with the Mass General Brigham Ventures focusing on early-stage investments and company creation. Previously, she was in the private/family office at Bracebridge Capital serving as Director of Private Investments where she led investments in early-stage life science companies. Prior to that role, she led business development for Ginkgo BioWorks and was Senior Director at PureTech Ventures. She spent several years working as a scientist in anti-viral drug discovery for Idenix Pharmaceuticals and Anadys Pharmaceuticals. Meredith received her undergraduate degree from Mount Holyoke College, her MBA from the MIT Sloan School of Management, and her PhD from Harvard University. While at Harvard, she co-founded Harvard Graduate Women in Science and Engineering (HGWISE). Meredith represents the fund on the boards of BraveBio, Violet, Mediar, Nocion, ClarisBio and ZielBio as well as serving as an Observer for Scorpion and Amolyt.

Gregory Verdine is a leader in the discovery, development and commercialization of new drug modalities. A passionate and accomplished inventor of novel approaches and drug classes to engage targets widely believed intractable, Greg coined the phrase “drugging the undruggable” to describe his life mission. LifeMine is the brainchild of Greg, who as a venture partner of WuXi Healthcare Ventures, led the founding team that brought the company from concept to reality. In his role as President, CEO and CSO of LifeMine, Greg is leading the company through its ramp-up and march toward the clinic. Greg is highly regarded for having moved seamlessly between roles as an academic scientist, biotech entrepreneur, investor, and company executive. He has served on the board of directors of Enanta Pharmaceuticals, Wave Life Sciences, Warp Drive Bio, and FOG Pharmaceuticals. Greg has led the creation of 10 startups, and also led the financing of Wave Life Sciences, Warp Drive Bio and FOG, taking a role in managing these companies as their president, chief executive officer and chief scientific officer. Greg earned his Ph.D. in chemistry from Columbia University, a B.S. in chemistry from St. Joseph’s University and served as an NIH postdoctoral fellow in molecular biology at MIT and Harvard Medical School.

 Full Bio